Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Promising preclinical data for AK-119 as potential immunotherapy for COVID-19

Nov. 20, 2020

New HBsAg and HBeAg secretion inhibitors discovered at Nanjing Hepo Pharmaceuticals

Nov. 20, 2020

FLUVID influenza-COVID-19 therapeutic cocktail demonstrates effective antiviral activity

Nov. 20, 2020

Interim data from phase Ib/IIa study of VBI-2601 for chronic hepatitis B

Nov. 19, 2020

BioVersys initiates phase I testing of BV-100 for carbapenem-resistant A. baumannii infections

Nov. 19, 2020

Beta Pharma identifies new HCV NS5A inhibitors

Nov. 19, 2020

Neuro-drug repurposed to treat MDR Gram-negative sepsis

Nov. 19, 2020

'Superkiller' is broad-spectrum antiviral target

Nov. 19, 2020

EMA and Swissmedic begin rolling reviews of COVID-19 vaccine candidate mRNA-1273

Nov. 18, 2020

The unusual suspects: Test rapidly diagnoses any known pathogen from any available body fluid

Nov. 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.